You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SH2B1 deficiency obesity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Genetic Obesity, POMC Deficiency Obesity, PCSK1 Deficiency Obesity Trial in Paris, Cambridge (LB54640)

Not yet recruiting
  • Genetic Obesity
  • +3 more
  • Paris, France
  • +1 more
Sep 20, 2023

Patients With Obesity and Specific Gene Defects in the Melanocortin-4 Receptor Pathway Trial (Setmelanotide, Placebo)

Not yet recruiting
  • Patients With Obesity and Specific Gene Defects in the Melanocortin-4 Receptor Pathway
  • (no location specified)
Oct 13, 2021

Pro-opiomelanocortin (POMC) Deficiency Obesity (Heterozygous or Epigenetic), Leptin Receptor Deficiency Obesity, Smith-Magenis

Completed
  • Genetic Obesity
  • +2 more
  • Birmingham, Alabama
  • +57 more
Dec 22, 2022

Bardet-Biedl Syndrome, POMC Deficiency Obesity, PCSK1 Deficiency Obesity Trial in Worldwide (Setmelanotide)

Active, not recruiting
  • Bardet-Biedl Syndrome
  • +3 more
  • Aurora, Colorado
  • +5 more
Jul 21, 2022

Atherosclerosis, Cardiovascular Diseases, Diabetes, Type 2 Trial in North York, Scarborough (Semaglutide Pen Injector)

Recruiting
  • Atherosclerosis
  • +3 more
  • Semaglutide Pen Injector
  • North York, Ontario, Canada
  • +1 more
May 12, 2023

Ornithine Transcarbamylase (OTC) Deficiency Trial in Worldwide (scAAV8OTC, Oral prednisone)

Completed
Has Results
  • Ornithine Transcarbamylase (OTC) Deficiency
  • scAAV8OTC
  • +2 more
  • Aurora, Colorado
  • +8 more
Jan 23, 2023

Baby Detect : Genomic Newborn Screening

Recruiting
  • Congenital Adrenal Hyperplasia
  • +126 more
    • Liege, Wallonia, Belgium
      CRMN, Hôpital La Citadelle
    Jan 24, 2023

    Overweight or Obesity, CKD, Type 2 Diabetes Trial in Worldwide (LY3437943, Placebo)

    Not yet recruiting
    • Overweight or Obesity
    • +2 more
    • Canoga Park, California
    • +19 more
    Jun 30, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +36 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jan 23, 2023

    Immune Deficiency Disease Trial in Tuebingen, Frankfurt am main, Berlin (CoVAC-1)

    Active, not recruiting
    • Immune Deficiency Disease
    • CoVAC-1
    • Tuebingen, Baden-Wuerttemberg, Germany
    • +2 more
    Jan 14, 2022

    Obesity, Iron Deficiency Anemia Trial (Calorie-restricted diet with red meat, Calorie-restricted diet without red meat)

    Not yet recruiting
    • Obesity
    • Iron Deficiency Anemia
    • Calorie-restricted diet with red meat
    • Calorie-restricted diet without red meat
    • (no location specified)
    Oct 23, 2023

    Overweight and/or Obesity Trial in Brussels (PF-06882961 100 mg)

    Completed
    • Overweight and/or Obesity
    • PF-06882961 100 mg
    • Brussels, Bruxelles-capitale, Région DE, Belgium
      Brussels Clinical Research Unit
    Mar 23, 2022

    Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome Trial in Minneapolis (Stem Cell Transplantation, IMD

    Recruiting
    • Mucopolysaccharidosis Disorders
    • +28 more
    • Stem Cell Transplantation
    • +7 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Nov 1, 2022

    Obesity Trial in Netherlands, United Kingdom (Allurion Digital Behaviour Change Intervention)

    Completed
    • Obesity
    • Allurion Digital Behaviour Change Intervention
    • Nederland, AB Hilversum, Netherlands
    • +3 more
    May 22, 2023

    Alpha-1 Antitrypsin Deficiency, AATD Trial in New Zealand, United Kingdom, United States (INBRX-101/rhAAT-Fc)

    Recruiting
    • Alpha-1 Antitrypsin Deficiency
    • AATD
    • Sacramento, California
    • +9 more
    Feb 15, 2022

    Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial

    Recruiting
    • Recurrent Acute Lymphoblastic Leukemia
    • +15 more
    • Anti-CD19/CD20/CD22 CAR T-Cells
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 4, 2022

    Overweight, Obesity Trial in New Haven (Formulation A (PF-07081532 20 mg plus 60 mg), Formulation B (PF-07081532 80 mg))

    Recruiting
    • Overweight
    • Obesity
    • Formulation A (PF-07081532 20 mg plus 60 mg)
    • Formulation B (PF-07081532 80 mg)
    • New Haven, Connecticut
      New Haven Clinical Research Unit
    Jan 25, 2023

    Obesity, Type 2 Diabetes Trial in Halifax, Quebec City (Self Forming Magnetic (SFM) Anastomosis System)

    Recruiting
    • Obesity
    • Type 2 Diabetes Mellitus
    • Self Forming Magnetic (SFM) Anastomosis System
    • Halifax, Nova Scotia, Canada
    • +1 more
    Dec 16, 2021

    Metabolic Syndrome Trial in Québec (INV-202, Placebo)

    Completed
    • Metabolic Syndrome
    • Québec, Quebec, Canada
      Syneos Health Clinique Inc
    Oct 3, 2022

    Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)

    Recruiting
    • Hereditary Angioedema
    • +9 more
    • Birmingham, Alabama
    • +21 more
    Aug 11, 2022

    Diabetes, Obesity Trial in Worldwide (PF-07081532, Placebo, Rybelsus)

    Recruiting
    • Diabetes Mellitus
    • Obesity
    • Centreville, Alabama
    • +55 more
    Jan 18, 2023

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL Trial in Seattle (biological,

    Recruiting
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +20 more
    • Chimeric Antigen Receptor T-Cell Therapy
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 11, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Cyclophosphamide, Fludarabine Phosphate, Ibrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Hidradenitis Suppurativa Trial in Canada, Poland, United States (Izokibep, Placebo to izokibep)

    Recruiting
    • Hidradenitis Suppurativa
    • Encino, California
    • +51 more
    Feb 1, 2023

    Recurrent Anaplastic Large Cell Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Classic Hodgkin Lymphoma Trial in

    Recruiting
    • Recurrent Anaplastic Large Cell Lymphoma
    • +9 more
    • Anti-CD30/CD16A Monoclonal Antibody AFM13
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 9, 2022